Navigation Links
Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
Date:9/13/2007

with symptoms suggestive of mechanical gastrointestinal obstruction should be evaluated to confirm the absence of such an obstruction prior to initiating AMITIZA treatment.

The safety of AMITIZA in pregnancy has not been evaluated in humans. In guinea pigs, lubiprostone has been shown to have the potential to cause fetal loss. AMITIZA should be used during pregnancy only if the benefit justifies the potential risk to the fetus. Women who could become pregnant should have a negative pregnancy test prior to beginning therapy with AMITIZA and should be capable of complying with effective contraceptive measures.

Patients taking AMITIZA may experience nausea. If this occurs, concomitant administration of food with AMITIZA may reduce symptoms of nausea.

AMITIZA should not be administered to patients that have severe diarrhea. Patients should be aware of the possible occurrence of diarrhea during treatment. If the diarrhea or nausea becomes severe, patients should consult their health professional.

In clinical trials for Chronic Idiopathic Constipation (24 mcg, oral gel capsules, twice daily), the most common adverse reaction was nausea (29%). Other adverse reactions (greater than or equal to 4% of patients) included diarrhea (12%), headache (11%), abdominal pain (8%), abdominal distension (6%) and flatulence (6%).

For full prescribing information, visit http://www.amitiza.com.

AMITIZA(R) is a registered trademark of Sucampo Pharmaceuticals, Inc.

Sucampo Pharmaceuticals, Inc.

Sucampo Pharmaceuticals, Inc., an emerging pharmaceutical company based in Bethesda, Md., focuses on the development and commercialization of drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. The therapeutic potential of prostones was first identified by Ryuji Ueno, M.D., Ph.D., Ph.D., Sucampo Pharmaceuticals' chairman and chief ex
'/>"/>

SOURCE Sucampo Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
3. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
4. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting
5. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
6. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
7. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
8. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
9. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
10. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
11. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- NxStage Medical, Inc. (Nasdaq: NXTM ), ... announced that a group of its home hemodialysis ... a week-long, conventional (non-dialysis) Caribbean cruise with their ... the "2010 Freedom Cruise: We,re Taking Home Dialysis ... 3, 2010 and returns on January 10, 2010. ...
(Date:12/15/2009)... IRVINE, Calif., Dec. 15 Masimo (Nasdaq: ... and Measure-Through Motion and Low Perfusion pulse oximetry, ... Kiani has been awarded the 2009 Frost & ... North American Patient Monitoring market. According to Frost ... of Mr. Kiani,s "unprecedented ability in understanding customer ...
(Date:12/15/2009)... 15 Arlington Medical Resources (AMR) and ... (MRSA) is the most concerning pathogen to ... their treatment of skin and skin structure infections. ... top factors that influences European physician drug selection ... key factors that drive prescribing include an agent,s ...
Breaking Medicine Technology:Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 3Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 4Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 2Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 3Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 4Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 5Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 6A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 2A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 3New Video Post Shows Minimally Invasive Procedure To Correct Sunken Chest Syndrome 60600 1New Video Post Shows Minimally Invasive Procedure To Correct Sunken Chest Syndrome 60600 2MDS Inc and Danaher Corporation Receive Second Request for Information from U S Federal Trade Commission for MDS Analytical Technologies Sale 60598 1MDS Inc and Danaher Corporation Receive Second Request for Information from U S Federal Trade Commission for MDS Analytical Technologies Sale 60598 2Triple S Management Corporation Reports Third Quarter 2009 Results 60596 1Triple S Management Corporation Reports Third Quarter 2009 Results 60596 2Triple S Management Corporation Reports Third Quarter 2009 Results 60596 3Triple S Management Corporation Reports Third Quarter 2009 Results 60596 4Triple S Management Corporation Reports Third Quarter 2009 Results 60596 5Triple S Management Corporation Reports Third Quarter 2009 Results 60596 6Triple S Management Corporation Reports Third Quarter 2009 Results 60596 7Triple S Management Corporation Reports Third Quarter 2009 Results 60596 8Triple S Management Corporation Reports Third Quarter 2009 Results 60596 9Triple S Management Corporation Reports Third Quarter 2009 Results 60596 10Triple S Management Corporation Reports Third Quarter 2009 Results 60596 11Triple S Management Corporation Reports Third Quarter 2009 Results 60596 12Triple S Management Corporation Reports Third Quarter 2009 Results 60596 13Triple S Management Corporation Reports Third Quarter 2009 Results 60596 14Triple S Management Corporation Reports Third Quarter 2009 Results 60596 15Triple S Management Corporation Reports Third Quarter 2009 Results 60596 16
... ... treatment, Dr. Carl Giordano - based in Morristown - among first surgeons selected ... provide ... July 29 Leading New Jersey orthopedic,surgeon Dr. Carl Giordano, of Morristown-based Atlantic Spine ...
... Inc.,(Nasdaq: MITI ), a biopharmaceutical company developing ... and autoimmune,diseases, today announced that it will host ... 7, 2008, at 9:00 am Eastern Time (3:00 ... 2008 financial,results. Micromet anticipates releasing its financial results ...
Other Medicine Technology:NJ-Based Surgeon Helps Pioneer Dramatic Advance in Treating Damaged Discs 2Micromet, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results 2Micromet, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results 3
(Date:12/15/2009)... but not delivered ,, WASHINGTON, Dec. 15 ... to ensure that healthcare reform does not override ... insurance companies in 37 states. ,, Prostate cancer ... the population and individuals who are identifiable as ... who have a family history of prostate cancer. ...
(Date:12/15/2009)... Dec. 15 Team In Training (TNT), ... charity sports training program, has reached a ... blood cancer research and patient services. ,, For ... pre-eminent charity endurance sports training program, preparing amateurs ... marathon, triathlon, 100-mile century cycle ride or hike ...
(Date:12/15/2009)... Dec. 15 North American application activity ... November year-over-year, according to the MIB Life ... applications over the past three months have lifted ... of -1.6%, to flat at November,s close, -0.1%. ... interest in the benefits available from life insurance," ...
(Date:12/15/2009)... service, such as tutoring children, can help older ... to a study led by researchers at the ... functional magnetic resonance imaging (fMRI), the researchers found ... made gains in key brain regions that support ... daily life. The study is the first of ...
(Date:12/15/2009)... early to say that phthalates actually cause ... (HealthDay News) -- Common chemicals found in plastic ... growth of breasts in boys, preliminary research suggests. ... medical journal for pediatricians, adds fuel to the ... has been questioned by some scientists. The chemical ...
Breaking Medicine News(10 mins):Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2Health News:$1 Billion - For Charity! 2Health News:$1 Billion - For Charity! 3Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3Health News:For older adults, participating in social service activities can improve brain functions 2Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 2Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 3
... We have previously shown that E2 and P4 have ... epithelial changes during early H. pylori infection. Recently, Ohtani ... administration in H. pylori-infected InGas mice. Other studies have ... murine gastric mucosa. ER and PR have been reported in ...
... Connections,Between Pay and Performance and Streamlines Talent ... Salary.com, Inc.,(Nasdaq: SLRY ), a ... solutions, today announced that Pacira Pharmaceuticals, an ... Parsippany, New,Jersey and La Jolla and San ...
... Oct. 31 Thousands of,people will be able to ... held at or near polling sites across the United ... & Vax project, a non-partisan and,non-political public health effort ... are taking place in 41 states plus the District ...
... Team up to Help Local Children,s Hospitals Across the ... ... year,Aflac will introduce a new plush duck for the holidays. The Aflac Holiday,Duck ... http://www.aflacholidayduck.com . Proceeds from,the sale of the Holiday Duck go toward ...
... out excess calcium, study finds , , FRIDAY, Oct. 31 (HealthDay ... loss in humans has been identified by European researchers. , ... called Oblivion had problems with the function of hair cells ... of the Oblivion gene, ear hair cells showed some initial ...
... an exaggerated intestinal immune response to otherwise innocuous ... plays a key role in the pathophysiology of ... yet emerged. Vitamin E is a major lipophilic ... which protects membrane lipids from peroxidation by scavenging ...
Other Medicine News:Health News:Estrogen and progesterone receptor isoforms expression in the stomach of Mongolian gerbils 2Health News:Estrogen and progesterone receptor isoforms expression in the stomach of Mongolian gerbils 3Health News:Pacira Pharmaceuticals Leverages TalentManager(R) from Salary.Com(TM) to Integrate Compensation and Performance Management Processes 2Health News:Pacira Pharmaceuticals Leverages TalentManager(R) from Salary.Com(TM) to Integrate Compensation and Performance Management Processes 3Health News:Vote & Vax Flu Shot Clinics Operating at More Than 250 Polling Sites Nationwide 2Health News:Aflac Duck Gives Back 2Health News:Aflac Duck Gives Back 3Health News:Mutant Mouse Gene Offers Clues to Hearing Loss 2Health News:Can rectal vitamin E induce remission in patients with mild to moderate ulcerative colitis? 2
... Ultra Micro Shafts For Insertion Through A ... Light-Weight ... Shafts For A More Comfortable Approach., ,Recessed ... Cap Supplied For Protection Of Jaws During ...
The New Easy-To-Use Disposable Diamond Knife Cleaning System Can Remove Even Baked-On Debris In Seconds. It Is Much More Effective Than Steam Or Blocks Of Styrofoam, Much Safer For Employees As Wel...
... Of Corneal Gauges Allowing The Exact,Outer Diameter ... 13.0mm, With 0.25mm ,Increments.,Easy And Quick To ... Gauge And Place Over A Cornea For ... In The USA, ...
... Gauge Measures 360 Degrees & Can Be ... A Cornea. 7mm Inner Diameter & 14mm Outer ... Only Astigmatism Gauge That Can Be Set For ... Degree Around The Globe., ,Marks Single Or Paired ...
Medicine Products: